111 Inc

111 Inc

YI · NASDAQ · Healthcare / Medical Distribution

2.84USD-0.01 (-0.35%)

Price History

Full chart

Market Stats

Previous Close2.85
Open2.87
Day Range2.84 – 2.93
52-Week Range2.48 – 8.53
Volume4.26K
Market Cap30.79M
P/E (TTM)0.00
Forward P/E0.00
EPS-1.79
Dividend Yield0.00%
Beta0.65
50-Day Avg3.62
200-Day Avg5.09

About

111, Inc., together with its subsidiaries, operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2C and B2B. The company offers supply chain integration services that help pharmaceutical companies manage products through online and offline channels; product promotion, customer analytics, patient education, and brand awareness services; and marketing and channel data services. It also provides 1 Pharmacy online wholesale pharmacy that offers pharmaceutical and other health and wellness products; and 1 Medicine Marketplace online retail pharmacy that provides drugs, nutritional supplements, medical supplies and devices, personal care, and baby products. In addition, the company offers online loan application services; cloud-based inventory management services; smart procurement services, which collect pharmacies' historical purchase orders and inventory data; and Hawkeye automated salesforce tool, as well as online consultation, e-prescription, and data services. Further, its pharmacies provide drugs, including prescription and over-the-counter drugs comprising Western and Chinese medicines; nutritional supplements, such as vitamins and dietary products; contact lenses; medical supplies and devices that consists of bandages and thermometers; and personal care products that include skin care, birth control, sexual wellness, and baby products. Additionally, the company offers research and development, and consulting services; warehousing, procurement, and logistics services; and software development and information technology support services. It serves pharmacies, pharmaceutical companies, medical professionals, and marketplace sellers. The company was formerly known as New Peak Group and changed its name to 111, Inc. in April 2018. 111, Inc. was founded in 2010 and is headquartered in Shanghai, the People's Republic of China.

Company Details

  • SectorHealthcare
  • IndustryMedical Distribution
  • CEOMr. Junling Liu
  • Employees1.06K
  • HeadquartersNo.295 ZuChongZhi Road, Shanghai, China, 201203, USA
  • Websitehttps://corporate.111.com.cn

Leadership

  • Dr. Gang Yu Ph.D.Co-Founder & Executive Chairman · b. 1959
  • Mr. Junling LiuCo-Founder, Acting CFO, Chairman & CEO · b. 1965
  • Monica MuIR Director
  • Mr. Anfeng GuoChief Innovation Officer
  • Mr. Alex LiuFinance Director

Financials

Income Statement

Currency: CNY2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue873.84M959.49M1.79B3.95B8.20B12.43B13.52B14.95B14.40B12.21B
Growth (%)-+9.80%+86.14%+121.28%+107.57%+51.48%+8.78%+10.59%-3.66%-15.19%
Cost of Revenue796.23M868.72M1.68B3.79B7.84B11.80B12.68B14.10B13.57B11.51B
Gross Profit77.61M90.77M104.27M165.18M365.83M621.10M839.98M848.98M829.23M703.70M
Gross Margin8.88%9.46%5.84%4.18%4.46%5.00%6.21%5.68%5.76%5.76%
Operating Expense441.89M344.79M504.64M658.70M839.14M1.26B1.21B1.20B827.12M713.73M
Operating Income-364.28M-254.02M-400.38M-493.51M-473.31M-642.14M-371.00M-350.10M2.11M-10.03M
Operating Margin-41.69%-26.47%-22.42%-12.49%-5.77%-5.17%-2.74%-2.34%0.01%-0.08%
EBITDA-350.63M-234.45M-382.03M-486.54M-444.27M-588.32M-321.81M-311.26M24.62M1.81M
EBITDA Margin-40.13%-24.44%-21.39%-12.31%-5.42%-4.73%-2.38%-2.08%0.17%0.01%
Net Income-362.68M-248.58M-380.09M-499.61M-456.53M-669.81M-416.88M-392.69M-64.74M-16.84M
Net Income Margin-41.50%-25.91%-21.28%-12.64%-5.57%-5.39%-3.08%-2.63%-0.45%-0.14%
R&D61.77M48.13M71.25M61.90M92.08M189.28M139.50M124.34M-58.75M
R&D as % of Total Revenue7.07%5.02%3.99%1.57%1.12%1.52%1.03%0.83%-0.48%
Interest Expense751.00K55.00K03.62M8.82M5.49M13.44M20.14M28.33M34.60M
Interest Expense % of Total Revenue0.09%0.01%0.00%0.09%0.11%0.04%0.10%0.13%0.20%0.28%

Balance Sheet

Currency: CNY2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets941.61M763.38M1.55B1.61B3.03B3.15B3.47B3.09B2.79B2.20B
Total Liabilities366.08M444.56M322.65M836.37M1.70B2.30B2.83B2.81B2.41B1.99B
Total Equity575.52M318.82M1.22B776.66M357.40M-173.32M-414.60M-583.45M-642.64M-702.68M
Cash373.50M167.66M853.74M613.75M1.19B661.39M673.67M603.52M462.29M561.66M
Total Debt50.68M43.40M2.47M208.76M329.35M491.01M344.19M443.23M256.77M217.73M
Net Debt-373.50M-167.66M-853.74M-461.65M-860.27M-170.38M-329.48M-160.29M-205.52M-343.93M

Cash Flow

Currency: CNY2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-388.65M-204.37M-343.02M-510.19M-116.78M-641.94M-23.15M-447.24M263.02M119.14M
Investing Cash Flow-267.55M-36.13M44.45M237.68M-324.67M60.14M-47.17M151.74M37.38M-53.72M
Financing Cash Flow148.42M49.50M972.70M106.95M1.07B27.44M22.73M205.98M-406.24M-21.19M
Capital Expenditure6.92M6.86M14.82M24.61M25.50M62.69M31.57M9.82M15.20M4.45M
Free Cash Flow-395.57M-211.23M-357.84M-534.80M-142.28M-704.63M-54.73M-457.07M247.82M114.69M
Dividends Paid000148.88M264.60M359.94M----
FCF to OCF101.78%103.36%104.32%104.82%121.84%109.77%236.38%102.20%94.22%96.26%
Dividend Paid to FCF0.00%0.00%0.00%-27.84%-185.97%-51.08%----

Earnings

Report DateMar 31, 2017Jun 30, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Sep 13, 2018Nov 8, 2018Mar 7, 2019May 16, 2019Aug 15, 2019Nov 14, 2019Mar 12, 2020May 21, 2020Aug 20, 2020Nov 19, 2020Mar 18, 2021May 19, 2021Aug 27, 2021Nov 19, 2021Mar 17, 2022Jun 16, 2022Aug 25, 2022Dec 1, 2022Mar 23, 2023Jun 15, 2023Aug 26, 2023Nov 30, 2023Mar 21, 2024May 23, 2024Aug 29, 2024Nov 28, 2024Mar 19, 2025Apr 29, 2025Sep 25, 2025Dec 17, 2025Apr 9, 2026Sep 17, 2026
EPS Estimate0.000.000.000.000.000.000.00----0.61-1.50-1.92-1.52-1.12-1.32-1.58-1.78-1.92-3.04-1.34-1.32-1.14-1.16-1.38-0.38-0.68-----------
EPS Actual-0.25-0.25-0.26-0.27-0.19-0.36-0.41-2.77-1.54-1.46-0.61-1.50-1.92-1.52-1.12-1.32-1.58-1.78-1.92-3.04-1.34-1.32-1.14-0.10-0.08-0.38-0.68-0.78-0.34-0.02-0.02-0.03-0.32-2.30-0.31-0.21-0.26-0.60
Surprise----------0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%91.38%94.20%0.00%0.00%-----------
Timing------After-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-After-hoursPre-market--

Key Statistics & Ratios

Market Cap30.79M
Enterprise Value31.20M
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.00
Price / Book17.66
EPS-1.79
Book Value-12.52
Revenue (TTM)10.48B
Gross Profit (TTM)314.88M
EBITDA-36.55M
Profit Margin-1.01%
Operating Margin-1.01%
Return on Equity-27.53%
Return on Assets-1.34%
Shares Outstanding5.20M
Shares Float4.66M
Beta0.65
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Ownership Breakdown

Institutions
0.62%
Insiders
9.93%
Retail / Other
89.45%

Top Institutional Holders

  • Citadel Advisors Llc
    17.34K0.20%
  • Renaissance Technologies Corp
    13.01K0.15%
  • Serenus Wealth Advisors, LLC
    4.32K0.05%
  • Citigroup Inc
    2070.00%
  • SBI Securities Co Ltd
    1440.00%
  • Morgan Stanley - Brokerage Accounts
    1130.00%
  • UBS Group AG
    1000.00%
  • JPMorgan Chase & Co
    520.00%
  • Rhumbline Advisers
    220.00%
  • Susquehanna International Group, LLP
    00.00%
  • Parafestas Anastasios
    00.00%

Top Fund Holders

  • Fidelity Nasdaq Composite Index
    2.36K0.03%

Stock Splits

  • Jan 24, 20251:10